Monday

 
09:00 - 16:15
Building a brighter future: Addressing challenges in patient care Building a brighter future: Addressing challenges in patient care

Organised by Novo Nordisk

 
Beringer Hall
 
09:00 - 17:00
Addressing Diabetes Challenges Across the Continuum of Care Addressing Diabetes Challenges Across the Continuum of Care

Organised by Sanofi Diabetes

 
Young Hall
 
09:00 - 13:00
1. Title: Perspectives on GLP-1RA therapy advancements in T2DM 2.Title: New Insulin therapies in the horizon 1. Title: Perspectives on GLP-1RA therapy advancements in T2DM 2.Title: New Insulin therapies in the horizon

Organised by Eli Lilly and Company

 
Creutzfeldt Hall
 
10:00 - 12:30
Next Frontier in Diabetes Management : Will Flash Glucose Monitoring deliver improved outcomes? Next Frontier in Diabetes Management : Will Flash Glucose Monitoring deliver improved outcomes?

Organised by Abbott

 
Derot Hall
 
10:00 - 12:30
Current Developments in Diabetic Hypoglycaemia Current Developments in Diabetic Hypoglycaemia

Organised by International Hypoglycaemia Study Group

 
Pyke Hall
 
10:30 - 16:30
Modern Type 2 diabetes management: The experts’ guide to the universe of choices Modern Type 2 diabetes management: The experts’ guide to the universe of choices

Organised by AstraZeneca

 
Lundbaeck Hall
 
11:00 - 12:30
Cardiovascular management in your angina patients with Type 2 diabetes: a critical unmet need Cardiovascular management in your angina patients with Type 2 diabetes: a critical unmet need

Organised by A. Menarini

 
Sutherland Hall
 
14:00 - 16:30
A special report on Type 2 Diabetes: Finding the right treatment routes to optimize your patients’ journey A special report on Type 2 Diabetes: Finding the right treatment routes to optimize your patients’ journey

Organised by Boehringer Ingelheim & Eli Lilly and Company

 
Creutzfeldt Hall
 
14:00 - 17:00
Visualising the patient journey in type 2 diabetes Visualising the patient journey in type 2 diabetes

Organised by Novartis Pharmaceuticals

 
Renold Hall
 
14:00 - 17:25
C-Peptide and the Pathophysiology of Diabetes C-Peptide and the Pathophysiology of Diabetes

Organised by C-Peptide Action Group

 
Courtyard by Marriott Hotel – Prater 3+4
 
14:30 - 17:00
Debating the next step for long-term control with GLP-1 receptor agonists: what's new, what's next – what now? Debating the next step for long-term control with GLP-1 receptor agonists: what's new, what's next – what now?

Organised by GlaxoSmithKline

 
Randle Hall
 
14:30 - 17:00
The Role of Sitagliptin in the Individualized Treatment of the Patient With Type 2 Diabetes The Role of Sitagliptin in the Individualized Treatment of the Patient With Type 2 Diabetes

Organised by Merck Sharp & Dohme

 
De Duve Hall
 
14:30 - 17:00
The journey to optimized insulin therapy: how new diagnostic concepts and technology can support people with diabetes and their healthcare professionals The journey to optimized insulin therapy: how new diagnostic concepts and technology can support people with diabetes and their healthcare professionals

Organised by Roche Diagnostics

 
Sutherland Hall
 
14:30 - 17:00
Investigating the different dimensions of DPP-4 inhibitors Investigating the different dimensions of DPP-4 inhibitors

Organised by Takeda

 
Derot Hall
 
14:30 - 17:00
SGLT2 inhibition: a new therapeutic option for individualized management of type 2 diabetes SGLT2 inhibition: a new therapeutic option for individualized management of type 2 diabetes

Organised with the support of Janssen Pharmaceutical Companies of Johnson & Johnson in EMEA

 
Pyke Hall
 
14:30 - 17:00
Insuline - Medical Symposium Insuline - Medical Symposium

Organised by Insuline Medical

 
Oberdisse Hall